Dermatologic adverse events to chemotherapeutic agents, Part 1: Cytotoxic agents, epidermal growth factor inhibitors, multikinase inhibitors, and proteasome inhibitors

Rachel L. Kyllo, Milan J. Anadkat

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Dermatologic adverse events to chemotherapeutic agents, Part 1: Cytotoxic agents, epidermal growth factor inhibitors, multikinase inhibitors, and proteasome inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences